Dr. Reddys Laboratories Limited operates as an integrated pharmaceutical company. The company has a presence in markets, such as the United States, the United Kingdom and Germany, as well as other markets, such as India, Russia, Venezuela, Romania, South Africa and certain countries of the former Soviet Union.SegmentsThe company operates in three business segments Global Generics segment, which includes its branded and unbranded prescription and over-the-counter (OTC) drug products business, as well as its biologics business Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its Active Pharmaceutical Ingredients (API) business and Custom Pharmaceutical Services (CPS) business and Proprietary Products segment, which consists of its Differentiated Formulations business, its new chemical entities business, and its dermatology focused specialty business operated through Promius Pharma LLC (Promius Pharma).Global Generics SegmentThis segment offers generic pharmaceutical.India In India, the companys key therapeutic categories include gastro-intestinal, cardiovascular, pain management and oncology. The company is also increasing its presence in the niche areas of dermatology, urology, and nephrology.As of March 31, 2014, the company had a total of 277 branded products in India. IMS Health is a provider of market research to the Indian pharmaceutical industry.Sales, Marketing and Distribution Network The company generates demand for its products through its 4,863 sales representatives and front line managers, who frequently visit doctors to detail its related product portfolio.The company sells its products primarily through clearing and forwarding agents to approximately 2,500 wholesalers who decide which brands to buy based on demand. The wholesalers pay for the companys products in an agreed credit period and in turn sell these products to retailers. Its clearing and forwarding agents are responsible for transporting its products to th
India
No information added
No information added
This company doesn't have any public Opportunities
Offices